Chime'sTribune

In an appallingly misguided bid to “protect” American businesses, President Donald Trump has unleashed a tariff onslaught that has become a death knell for investor confidence. His disastrous imposition of a staggering 104% tariff on Chinese goods—followed by a tit-for-tat escalation—has sent shockwaves through global financial markets, triggering an unprecedented sell-off of U.S. government bonds. Over the past days, as the administration continued to escalate its aggressive trade war, yields on 10-year U.S. Treasuries have surged from a modest 3.9% to an eye-watering 4.5%—a level unseen since February. This dramatic spike is not just a technical blip; it signals a profound erosion of faith in what was once the world’s safest asset class. The fallout is clear: companies face soaring borrowing costs, and American taxpayers will eventually shoulder the burden of higher interest payments. Even more damning is the evidence that while ordinary investors are scrambling to mitigate their los...

  Once celebrated for his environmental advocacy, Robert F. Kennedy Jr. has taken a sharp and troubling turn — one that’s placed him at the center of America’s public health dilemma, not as a steward of science, but as a megaphone for misinformation. As Secretary of Health and Human Services, Kennedy now commands oversight of the country’s top health institutions, including the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) . But instead of using this platform to champion evidence-based policy, Kennedy is treading a dangerous line: questioning vaccine safety while ostensibly encouraging vaccination. It’s a rhetorical balancing act that sends mixed signals at best — and fuels distrust at worst. In a recent interview with CBS News, Kennedy endorsed the measles vaccine — then, almost in the same breath, cast doubt on its safety. He falsely claimed the vaccine hasn’t been “properly tested” and that its protection is short-lived. Both ass...